Tuesday, August 7, 2012

New generic Singulair could save asthma sufferers big bucks

Asthma and allergy sufferers who take Singulair (montelukast) will soon be able to slash their medication bills. Late last week, the Food and Drug Administration approved the first generic version of the popular drug. And within the first year or so, the monthly cost of the generic is expected to drop to half or less of the $180 retail price tag of brand-name Singulair...

Keep reading at: news.consumerreports.org



Asthmapolis Expands Dignity Health Study to Include Mercy Medical Group Patients

MADISON, Wis., Aug. 6, 2012 /PRNewswire via COMTEX/ -- Asthmapolis announced today that it will be expanding its asthma study at Woodland Healthcare in Woodland, Calif. to also include patients from Mercy Medical Group, another Dignity Health system, located in neighboring Sacramento, Calif...

Continue reading at marketwatch.com



Study links mold to childhood asthma

While mold is considered an asthma trigger and risk factor for exacerbating asthma, new research links three mold species to childhood development of asthma, according to a study by University of Cincinnati researchers...

Read more at jsonline.com

No comments: